A Randomized , Open Label, Dose Titration Study to Evaluate the Effect of Pitavastatin Versus Atorvastatin in Patients With Hypercholesterolemia and Mild to Moderate Hepatic Damage.
Phase of Trial: Phase IV
Latest Information Update: 30 Mar 2012
At a glance
- Drugs Atorvastatin; Pitavastatin
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms PITCH
- Sponsors JW Pharmaceutical
- 10 Jun 2017 Biomarkers information updated
- 30 Mar 2012 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 30 Mar 2012 Company (JW Pharmaceutical) added, actual initiation date (Jun 2009) added and additional lead trial investigator (Kyoo-Rok Han) identified as reported by ClinicalTrials.gov.